Catalyst Wire Dossier Catalyst Wire Dossier

Autologous TCR-T cell therapy

TCR-engineered autologous T cells · Alaunos Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous TCR-T cell therapy, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors

See pricing